A truncating mutation in Alzheimer's disease inactivates neuroligin-1 synaptic function

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Neuroligins (NLs) are crucial cell-adhesion proteins regulating synapse formation and function.
• Neuroligin 1 (NL1) specifically promotes glutamatergic synapses and long-term potentiation.
• Dysfunctional NL1 is implicated in the synaptic and memory deficits observed in Alzheimer's disease (AD).

Purpose of the Study:

• To investigate the role of neuroligin 1 gene (NLGN1) mutations in Alzheimer's disease.
• To characterize a specific frameshift mutation in NLGN1 found in an AD patient.

Main Methods:

• Genetic sequencing to identify mutations in the NLGN1 gene.
• Expression studies of mutant NL1 protein.
• In vitro studies using hippocampal neurons to assess synaptic function.

Main Results:

• A frameshift mutation (c.875_876insTT) leading to a premature stop codon (p.Thr271fs) was identified in the NLGN1 gene of an AD patient.
• The mutant NL1 protein was truncated and accumulated in the endoplasmic reticulum.
• The p.Thr271fs mutation impaired NL1's ability to promote glutamatergic synapse formation in hippocampal neurons.

Conclusions:

• Inactivating mutations in NLGN1 are implicated in Alzheimer's disease.
• Altered neuroligin function may contribute to molecular mechanisms underlying age-related brain diseases like AD.
• This finding extends the role of NL dysfunction from neurodevelopmental disorders to neurodegenerative conditions.